hotspot -WSS

hotspot

author：fashion 2025-09-30 17:04:06 - browse：698

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

The Food and Drug Administration on Thursday approved an Eli Lilly drug that takes a new approach to treating ulcerative colitis, a chronic inflammatory disease that can cause intense gastrointestinal pain and distress.

The therapy, dubbed Omvoh, is an antibody that blocks IL-23p19, an immune signaling molecule that plays a key role in sustaining the disease. It’s the first treatment to target this particular pathway in ulcerative colitis. The drug’s approval comes after two late-stage trials found that patients taking Omvoh showed a significant improvement in symptoms after both three months and a year compared with those given a placebo, and that the therapy had minimal side effects.

Omvoh’s list price will be $9,593 per month for intravenous delivery and $10,360 per dose injected beneath the skin. A company spokesperson told STAT that patients who have the drug covered by commercial insurance may pay as little as $5 per month for up to 30 months.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： What PEPFAR has meant on the ground in Ukraine

entertainment

WSS

DeSantis wants to import drugs. Biden’s FDA blasted his plan

Teach medical students about patients with intellectual disabilities

People can get long Covid without testing positive for virus: Study

Roche's accidental data boosts hopes for anti

People can get long Covid without testing positive for virus: Study

Congenital heart disease patients face new threat of heart failure

explore

hotspot

knowledge

Walensky prepares to leave CDC — and Congress — behind

Listen: Vivek Ramaswamy's star turn & leaky drug data

Trump demands the U.S. pay no more for drugs than other countries … again

Roche to buy Carmot Therapeutics, developer of obesity drugs

Affirmative action in medical school literally saved lives

California store owner shot dead in dispute over displaying Pride flag: Police

Bright Health sells Medicare Advantage business to Molina

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

Sports medicine is finally prioritizing gender equality

CMS should re

hotspot

Teach medical students about patients with intellectual disabilities

Meadows told special counsel he could not recall Trump ever declassifying Mar

Former Pear Therapeutics executives start new VC firm

As obesity drug market grows, telehealth companies court payers

What causes an itch? Researchers may have solved the mystery

Roche to buy Carmot Therapeutics, developer of obesity drugs

leisure time

entertainment

entertainment

hotspot